|
STATEMENT OF ANTHONY S. FAUCI, M.D.
DIRECTOR, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NATIONAL INSTITUTES OF HEALTH ON NATIONAL LATINO AIDS AWARENESS DAY OCTOBER 15, 2009
October 15, 2009 - This seventh annual National Latino AIDS Awareness Day marks an occasion for all of us to consider the impact HIV has had on the Latino
community and what we can do to prevent future infections among the largest and fastest growing ethnic minority group in the United States.
Since the HIV/AIDS epidemic began, more than 82,000 Latinos in the United States have died.[1] While Latinos represent only 15 percent of the U.S. population,
they account for roughly 17 percent of new HIV infections each year and an estimated 18 percent of people living with HIV in this country.[2],[3] The Latino community also has a
disproportionate burden of newly diagnosed AIDS cases, with a rate three times that of whites.[4] And despite the fact that antiretroviral treatment for controlling HIV and
prolonging life is widely available in the United States, HIV/AIDS was the fourth leading cause of death among Latino men and women ages 35 to 44 in 2006.[5]
Within the Latino population, males are more frequently diagnosed with HIV/AIDS, with gay and bisexual Latinos experiencing the greatest burden of new
diagnoses. However, among all women, Latinas experience a high rate of new HIV infections accounting for 16 percent of new infections, nearly four
times the rate for white women but about a quarter of the rate among African-American women.[6]
A key concern is that a significant number of Latinos infected with HIV get tested for the virus late in the course of their disease. This means that many
individuals infected with HIV are not getting antiretroviral treatment at an earlier stage in their infection when medication could produce the best health outcomes. It also means that infected
individuals may unwittingly transmit the virus to others, continuing its ongoing spread throughout the community.
Cultural and socioeconomic factors, such as poverty, language barriers, immigration status, health care access and stigma surrounding homosexuality all
serve to hinder routine HIV/AIDS testing among Latinos and place the community at greater risk for infection. To successfully curb HIV incidence among Latinos, we must find a way to
overcome these barriers, actively reach out to Latinos and promote widespread, routine HIV testing.
One of the top priorities of the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, is to conduct and support the HIV/AIDS research that
can help improve the health of millions of people in the United States and around the world. Developing new strategies to prevent and treat HIV/AIDS requires the participation
of all communities, but particularly those that are most affected by the disease. In this way, we can find the approaches that will be most appropriate and relevant to
a given patient population.
Latino men and women play an important role in HIV/AIDS research as scientists, health care workers and clinical trial volunteers. They also lend an important
voice of support to family members and friends who are considering enrolling in clinical research. Today, we thank our clinical trial volunteers and all those who
have worked tirelessly to prevent the spread of HIV among the Latino community, and we reaffirm our efforts to find new and more effective HIV prevention
and treatment strategies.
Dr. Fauci is director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health in Bethesda, Maryland.
Media inquiries can be directed to the NIAID Office of Communications at 301-402-1663, e-mail: niaidnews@niaid.nih.gov.
NIAID conducts and supports research -- at NIH, throughout the United States, and worldwide -- to study the causes of infectious and immune-mediated diseases, and
to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site
at http://www.niaid.nih.gov.
The National Institutes of Health (NIH)-The Nation's Medical Research Agency-includes 27 Institutes and Centers and is a component of the U. S. Department
of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates
the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
REFERENCES:
1. Centers for Disease Control and Prevention (CDC). 2009. HIV/AIDS Surveillance Report, 2007. Vol. 19. Atlanta: U.S. Department of Health and Human Services, Centers
for Disease Control and Prevention. Available at http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2007report/default.htm.
2. USA QuickFacts, U.S. Census Bureau, http://quickfacts.census.gov/qfd/states/00000.html.
3. CDC. 2009. HIV/AIDS Surveillance Report, 2007. Vol. 19. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
Available at http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2007report/default.htm.
4. Ibid.
5. Web-based Statistics Query and Reporting System (WISQARS) leading causes of death reports, 2006. http://webappa.cdc.gov/sasweb/ncipc/leadcaus.html.
6. CDC. 2009. HIV/AIDS Surveillance Report, 2007, Vol. 19. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
Available at http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2007report/default.htm.
The National Institutes of Health (NIH) -- The Nation's Medical Research Agency -- includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human
Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
REFERENCE: Lombardi VC, Ruscetti FW, Gupta JD, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, and Mikovits JA. Detection of Infectious Retrovirus, XMRV,
in Blood Cells of Patients with Chronic Fatigue Syndrome. Online October 8, 2009. Science.
Contacts:
Laura Sivitz,
301-402-1663,
e-mail: sivitzl@niaid.nih.gov
Source: NIH News National Institutes of Health
http://www.nih.gov/news/health/oct2009/niaid-15.htm |
